DAVIS, Calif., Feb. 09, 2016 -- Marrone Bio Innovations, Inc. (MBI), (NASDAQ:MBII) today announced that it has submitted a new biological fungicide (MBI-110) to the U.S. Environmental Protection Agency. The broad spectrum product, MBI-110 is especially notable for its activity on downy mildews and white molds, as shown in two years of field trials in the U.S., Canada and Europe.
Growers have few choices of products that perform well on the group of fungi that cause downy mildew on grapes, potatoes, leafy greens and other crops. MBI-110 is the result of MBI’s directed screening discovery program to find a solution that addresses this specific market need. This product is also complementary to the diseases covered by Marrone Bio Innovations' first biofungicide, REGALIA®.
“We knew that new solutions for downy mildew were badly needed, so our team of scientists set out to find one,” said Dr. Pam Marrone, Founder and CEO of Marrone Bio Innovations. “Our screening platform tested more than 16,000 microbes against important plant pathogens and discovered this novel candidate with a broad spectrum of performance and stand-out activity against downy mildews.”
The active ingredient in MBI-110 is a new strain of Bacillus amyloliquefaciens, a bacterium isolated by Marrone Bio Innovation scientists from a soil sample in the United States. While this type of Bacillus is common in soil and other products contain the same species, MBI’s discovery is unique in its performance on downy mildews, white molds and Botrytis gray mold. The company has an issued patent on the novel strain in MBI-110.
Tests conducted at Marrone Bio Innovations’ research and development lab show that MBI-110 works by colonizing plant root hairs, leaves and other plant surfaces thereby preventing establishment of fungal and bacterial pathogens, including Sclerotinia, Macrophomina, Eutypa, Botrytis, Rhizoctonia, and Sclerotium. Additional laboratory tests indicate that the bacterium also produces natural compounds, some of which inhibit bacterial and fungal mycelial growth, as well as spore germination. Subsequent field studies validated good results against downy mildew and black rot on grapes and cucurbits, pink rot and late blight on potatoes, Cercospora leaf spot on sugar beets, and white mold on soybean, sunflower, beans, lettuce and canola.
About Marrone Bio Innovations
Smart. Natural. Solutions.
Marrone Bio Innovations, Inc. (NASDAQ:MBII) aims to lead the movement to a more sustainable world through the discovery, development and promotion of biological products for pest management and plant health. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have four products for agriculture on the market, a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.
Media Contact: Cory Ziskind ICR 646-277-1232 [email protected] Investor Contact: James Palczynski ICR 203-682-8229 [email protected]


SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Washington Post Publisher Will Lewis Steps Down After Layoffs
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Instagram Outage Disrupts Thousands of U.S. Users
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 



